author-photo

Mary Allen

National Institutes of Health

52

Papers

1393

Citations

Citation Trend

Filter By

Papers (34) Sort By

Journal Conference Others

Meta-analysis of HIV-1 vaccine elicited mucosal antibodies in humans.

2021
Show All
- Source
- Cite
- Save
Citations (4)
Benign ethnic neutropenia in a South African population, and its association with HIV acquisition and adverse event reporting in an HIV vaccine clinical trial.

2021 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (3)
Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial

2018 The Lancet HIV
Show All
- Source
- Cite
- Save
Citations (59)
Innovative approaches to track lymph node germinal center responses to evaluate development of broadly neutralizing antibodies in human HIV vaccine trials

2018 Vaccine
Show All
- Source
- Cite
- Save
Citations (8)
DNA Priming Increases Frequency of T-Cell Responses to a Vesicular Stomatitis Virus HIV Vaccine with Specific Enhancement of CD8+ T-Cell Responses by Interleukin-12 Plasmid DNA.

2017 Clinical and Vaccine Immunology
Show All
- Source
- Cite
- Save
Citations (23)
Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial

2017 PLOS Medicine
Show All
- Source
- Cite
- Save
Citations (80)
Sequential Immunization with gp140 boosts immune responses primed by modified vaccinia Ankara or DNA in HIV-uninfected South African participants

2016 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (13)
Continued Follow-Up of Phambili Phase 2b Randomized HIV-1 Vaccine Trial Participants Supports Increased HIV-1 Acquisition among Vaccinated Men.

2015 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (19)
HIV Vaccine-Induced Sero-Reactivity: A Challenge for Trial Participants, Researchers, and Physicians

2015 Vaccine
Show All
- Source
- Cite
- Save
Citations (25)
First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090).

2015 Open Forum Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (46)